Author's details

Name: Dave Feldman
Date registered: April 15, 2016

Latest posts

  1. Two Weeks of Coronavirus that Changed the World — March 23, 2020
  2. Documentary Update – Nine Weeks Around the World — March 2, 2020
  3. Documentary Weeks 5, 6, 7 – New Zealand, UAE, Europe — February 24, 2020
  4. Documentary Week 4 – Perth, Melbourne, Sydney — February 3, 2020
  5. Documentary Week 3 – Kuala Lumpur, Phuket, Singapore — January 28, 2020

Most commented posts

  1. Questions — 2,127 comments
  2. Remnant Cholesterol – What Every Low Carber Should Know — 993 comments
  3. Are you a Lean Mass Hyper-responder? — 886 comments
  4. High Triglycerides on Low Carb – And What to Do About It — 449 comments
  5. START HERE (Pinned) — 397 comments

Author's posts listings

Jan 20

Documentary Week 2 – Hong Kong, Okinawa, Shanghai

Jan 15

Take. This. Survey.

With this vital survey (5-8m of your time), we’re looking to gather a very large number of entries for our anonymised data pool. We’ll post graphs of the data in future articles and it will allow for strong information on some important decisions ahead. Thank you in advance for your contribution to the data! Click …

Continue reading »

Jan 01

Shooting for #TheCCDoc is About to Begin

Happy New Year! I dropped a series of tweets this morning that I’ll just repost here to keep it short and sweet… In five days we begin filming #TheCCDoc — a documentary on #Lipids, #HeartDisease, and the phenomenon of higher #LDL #Cholesterol observed in many following the #keto/#lchf lifestyle.https://t.co/zG0fOom8W8 1/9 — Dave Feldman (@DaveKeto) January …

Continue reading »

Dec 26

One Year, Not Five

We have some powerful news today – we now have it on strong authority that the followup time for the LMHR Measurement Project will be more than sufficient at one year, not five. Spencer, Tommy, and I have been consulting many people both individually and together, including a very high level imaging expert. And we’re now …

Continue reading »

Dec 26

Thoughts Regarding LDL-P, ApoB, and Remnants

This week, Peter Attia released Measuring cardiovascular disease risk and the importance of apoB on his blog. I think it’s well worth the read and highly encourage you to finish it first before reading the rest of this article. One quote in particular sums the article up well: While I have historically used LDL-P and …

Continue reading »

Older posts «

» Newer posts